CCM® therapy is covered by Medicare

Medicare and Medicare Advantage cover CCM® therapy for FDA-indicated patients aged 18 or older who have not undergone a heart transplant.
Click here for more information
  • Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden
  • Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden

Impulse Dynamics Appoints Five New Board Members

by Impulse Dynamics | Nov 12, 2021 | News and Events, Press Releases

NEWS Impulse Dynamics Appoints Five New Board Members New Directors Bring a Wealth of Relevant Experience MARLTON, N.J., November 12, 2021 — Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the...

Impulse Dynamics Announces First Optimizer Implant in China

by Impulse Dynamics | Nov 1, 2021 | Press Releases

NEWS IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., November 1, 2021 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure,...

Impulse Dynamics Receives FDA Approval to Modify Labeling for Optimizer Smart Medical Devices

by Impulse Dynamics | Oct 26, 2021 | Press Releases

PRESS RELEASE FDA Authorizes Removal of “NSR” From Indications for Use MARLTON, N.J., October 26, 2021 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S. Food and Drug...

Impulse Dynamics Expands Commercial Leadership Team

by Impulse Dynamics | Jul 19, 2021 | News and Events, Press Releases

PRESS RELEASE MARLTON, N.J., July 19, 2021 — Impulse Dynamics (USA) Inc., a company dedicated to improving the lives of people with heart failure (HF), today announced the appointment of Jason Spees to the position of President, Chief Commercial Officer. Spees, who...

Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China

by Impulse Dynamics | Feb 22, 2021 | News and Events, Press Releases

NEWS IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA NMPA Clears the Way for Impulse Dynamics to Deliver Hope for Heart Failure Population MARLTON, N.J., February 22, 2021 — Impulse Dynamics, a company dedicated to improving the lives of...
« Older Entries
Next Entries »

Recent Posts

  • Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy
  • Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
  • Late-breaking Results Show Efficacy for CCM in Patients With HFpEF
  • IMPULSE DYNAMICS COMPLETES $101M FINANCING ROUND
  • IMPULSE DYNAMICS ANNOUNCES FIRST IMPLANTS OF OPTIMIZER SMART MINI

Recent Comments

    Archives

    • November 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • January 2022
    • November 2021
    • October 2021
    • July 2021
    • February 2021
    • January 2021
    • April 2020
    • March 2020
    • December 2019
    • November 2019
    • October 2019
    • July 2019
    • March 2019
    • May 2018
    • December 2017
    • August 2017
    • May 2017
    • March 2017
    • September 2016
    • May 2016
    • March 2016
    • January 2016
    • November 2015
    • August 2015
    • July 2015
    • January 2015
    • December 2014

    Categories

    • News and Events
    • Press Releases

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org